| 2023
1) Chiba, Y., Okada, K., Hayashi, Y., Kumada, S., Onuki, Y.
Usefulness of Applying Partial Least Squares Regression to T2 Relaxation Curves for Predicting the Solid form Content in Binary Physical Mixtures.
Journal of Pharmaceutical Sciences, 112(4), 1041–1051.
2) Hayashi, Y., Noguchi, M., Oishi, T., Ono, T., Okada, K., Onuki, Y.,
Application of unsupervised and supervised learning to a material attribute database of tablets produced at two different granulation scales.
Int. J. Pharm. 123066.
3) Onuki, Y., 2023.
In Silico Technologies to Boost Pharmaceutical Development.
Chem. Pharm. Bull.
4) Hayashi, Y., Nakano, Y., Marumo, Y., Kumada, S., Okada, K., Onuki, Y.,
A Data-Driven Approach to Predicting Tablet Properties after Accelerated Test Using Raw Material Property Database and Machine Learning.
Chem. Pharm. Bull. 71, c22-00538.
5) Tsuji, T., Ono, T., Taguchi, H., Leong, K.H., Hayashi, Y., Kumada, S., Okada, K., Onuki, Y.,
Continuous Monitoring of the Hydration Behavior of Hydrophilic Matrix Tablets Using Time-Domain NMR.
Chem. Pharm. Bull. 71, c23-00214.
6) Ono, T., Okada, K., Tsuchiya, M., Hayashi, Y., Kumada, S., Onuki, Y.,
Continuous Monitoring of the Agglomeration and Sedimentation of Indomethacin Nanosuspensions Using T2 Relaxation Time with Time-Domain NMR.
Chem. Pharm. Bull. 71, c23-00207.
| 2022
1) Chiba Y, Okada K, Hayashi Y, Leong KH, Kumada S, Onuki Y,
Characterization of the salt and free base of active pharmaceutical ingredients based on NMR relaxometry measured by time domain NMR,
Chem. Pharm. Bull., 70 (2022) 162-168.
2) Onuki Y, Sugiura D, Kumada S, Kobayashi R, Nakamura T, Kogawa T, Sakai H, Okada K,
The Molded Tablet, a disintegrant-free orally disintegrating tablet, resists thickening solution-reduced drug dissolution,
J. Drug Deliv. Sci. Technol., 69 (2022) 103179.
3) Tsuji, T., Kobayashi, R., Hayashi, Y., Kumada, S., Mizuguchi, M., Okada, K., Onuki, Y.
Determination of Hardness of a Pharmaceutical Oral Jelly by Using T2 Relaxation Behavior Measured by Time-Domain NMR.
Chem Pharm Bull., 70 (2022) 558-565.
4) Okada, K., Hayashi, Y., Tsuji, T., Onuki, Y.
Low-Field NMR to Characterize the Crystalline State of Ibuprofen Confined in Ordered or Nonordered Mesoporous Silica.
Chemical and Pharmaceutical Bulletin, 70(8) c22-00180.
5) Yamada, M., Ishikawa, A., Muramatsu, S., Furuishi, T., Onuki, Y., Fukuzawa, K., Yonemochi, E.
Study of Orally Disintegrating Tablets Using Erythritol as an Excipient Produced by Moisture-Activated Dry Granulation (MADG).
Pharmaceuticals, 15(8), 1004.
6) Iwata, H., Hayashi, Y., Hasegawa, A., Terayama, K., Okuno, Y.
Classification of scanning electron microscope images of pharmaceutical excipients using deep convolutional neural networks with transfer learning.
International Journal of Pharmaceutics: X, 4(August), 100135.
| 2021
1) Ougi, K., Hayashi, Y., Tsuji, T., Ito, T., Hoong Leong, K., Usuda, S., Kumada, S., Okada, K., Onuki, Y.,
Time-domain NMR analysis for the determination of water content in pharmaceutical ingredients and wet granules.
Int. J. Pharm. 120770.
2) Okada, K., Hayashi, Y., Kumada, S., Onuki, Y.,
Nondestructive Investigation of the Agglomeration Process for Nanosuspensions via NMR Relaxation of Water Molecules.
Eur. J. Pharm. Sci. 105908.
3) Matsuo, M., Okada, K., Onuki, Y., Yamazaki, M.,
Incompatibility of remimazolam besylate with Ringer’s acetate infusion resulting in total occlusion of an intravenous catheter.
BMJ Case Rep. 14, e241622.
4) Usuda, S., Masukawa, N., Leong, K.H., Okada, K., Onuki, Y.,
Effects of Manufacturing Process Variables on the Tablet Weight Variation of Mini-tablets Clarified by a Definitive Screening Design.
Chem. Pharm. Bull. 69, 896–904.
5) Hayashi, Y., Nakano, Y., Marumo, Y., Kumada, S., Okada, K., Onuki, Y.,
Application of machine learning to a material library for modeling of relationships between material properties and tablet properties.
Int. J. Pharm. 609, 121158.
| 2020
1) Oishi T, Hayashi Y, Noguchi M, Yano F, Kumada S, Takayama K, Okada K, Onuki Y,
Int. J. Pharm. 2020, 577.
2) Ikeuchi-Takahashi, Y., Ito, S., Itokawa, A., Ota, M., Onuki, Y., Hidaka, S., Onishi, H., Preparation and evaluation of orally disintegrating tablets containing taste masked microparticles of acetaminophen.
Pharmazie 2020. 75, 2–6.
3) Kosugi, A., Leong, K.H., Tsuji, H., Hayashi, Y., Kumada, S., Okada, K., Onuki, Y.,
Characterization of Powder- and Tablet Properties of Different Direct Compaction Grades of Mannitol Using a Kohonen Self-organizing Map and a Lasso Regression Model.
J. Pharm. Sci. 2020. 109, 2585–2593.
4) Okada, K., Hayashi, Y., Kumada, S., Onuki, Y.,
Quantitative Evaluation of the Crystallinity of Indomethacin Using 1H T2 Relaxation Behaviors Measured by Time Domain NMR.
J. Pharm. Sci. 2020. 109, 2577–2584.
5) Hayashi, Y.; Shirotori, K.; Kosugi, A.; Kumada, S.
A Precise Prediction Method for the Properties of API-Containing Tablets Based on Data from Placebo Tablets.
Pharmaceutics 2020, 1–13.
6) Ougi, K., Okada, K., Leong, K.H., Hayashi, Y., Kumada, S., Onuki, Y.,
Effect of the molecular mobility of water adsorbed by disintegrants on storage-induced hydrolytic degradation of acetylsalicylic acid incorporated into tablets under humid conditions.
Eur. J. Pharm. Sci. 2020. 154, 105502.
7) Kosugi, A. Leong, K.H. Urata, E. Hayashi, Y. Kumada, S. Okada, K. Onuki, Y.
Effect of Different Direct Compaction Grades of Mannitol on the Storage Stability of Tablet Properties Investigated Using a Kohonen Self-Organizing Map and Elastic Net Regression Model. Pharmaceutics 2020, 12, 886.
9) Yamamoto Y, Onuki Y, Fukami T, Koide T.
Comparison of various pharmaceutical properties of clobetasol propionate cream formulations- Considering stability of mixture with moisturizer-.
J. Pharm. Health Car. Sci. 2020 Jan; 6(1).
| 2019
1) Sahoo P, Leong K H, Nyamathulla S, Onuki Y, Takayama K, Chung L Y.
Chitosan complexed carboxymethylated iota- carrageenan oral insulin particles: Stability, permeability and in vivo evaluation.
Mater. Today Commun. 2019; 20(100557): 1-9.
2) Okada K, Hirai D, Kumada S, Kosugi A, Hayashi Y, Onuki Y,
1H NMR relaxation study to evaluate the crystalline state of active pharmaceutical ingredients containing solid dosage forms using time domain NMR
J. Pharm. Sci., 2019; 108(1) 451-456
3) Ito T, Okada K, Leong KH, Hirai D, Hayashi Y, Kumada S, Kosugi A, Onuki Y,
Chem. Pharm. Bull. 2019; 67, 271–276
4) Okada K, Hirai D, Hayashi Y, Kumada S, Kosugi A, Onuki Y,
Chem. Pharm. Bull. 2019; 67, 265–270
5) Hayashi Y, Marumo Y, Takahashi T, Nakano Y, Kosugi A, Kumada S, Hirai D, Takayama K, Onuki Y,
Int J Pharm, 2019; 558, 351-356
6) Tsuji T, Mochizuki K, Okada K, Hayashi Y, Obata Y, Takayama K, Onuki Y,
Int. J. Pharm., 2019; 563, 406-412
7) Okada K, Hirai D, Hayashi Y, Kumada S, Kosugi A, Onuki Y.
Chem. Pharm. Bull. 2019; 67, 580–586
8) Yoshimura-Fujii M, Yamamoto Y, Koide T, Hamaguchi M, Onuki Y, Suzuki N, Suzuki T, Fukami T.
Imaging analysis enables to differentiate distribution of pharmaceutical ingredients in tacrolimus ointments.
Appl. Spectrosc. 2019 Oct; 73(10): 1183-92.
| 2018
J Drug Deliv Sci Technol. 2018; Feb 43: 141-148
2) Hayashi Y, Oishi T, Shirotori K, Marumo Y, Kosugi A, Kumada S, Hirai D, Takayama K, Onuki Y,
Drug Dev Ind Pharm. 2018; 44(7): 1090−1098
3) Hayashi Y, Kosugi A, Miura T, Takayama K, Onuki Y,
Chem Pharm Bull. 2018; 66(5) 541−547
4) Hayashi Y, Okada N, Takayama K, Obata Y, Onuki Y,
Chem. Pharm. Bull. 2018; 66(7) 727−731
5) Phutthatiraphap S, Hayashi Y, Fujii T, Kosugi A, Okada K, Kadozaki T, Ishise T,
Sakai H, Onuki Y,
Chem. Pharm. Bull. 2018; 66(9) 896-900
6) Yokokawa M, Setoyama H, Okada K, Hayashi Y, Machida Y, Onuki Y, Obata Y,
Chem. Pharm. Bull. 2018; 66(11) 1078-1082
7) Ito T, Kida C, Okada K, Ikeda J, Otomura K, Hayashi Y, Obata Y, Takayama K, Onuki Y,
Langmuir, 2018; 34(40) 12093–12099
| 2017
1) Ishii-Mizuno Y, Umeki Y, Onuki Y, Watanabe H, Takahashi Y, Takakura Y, Nishikawa M.
Int J Pharm. 2017 Jan 10;516(1-2):392-400.
2) Yoshida S, Obata Y, Onuki Y, Utsumi S, Ohta N, Takahashi H, Takayama K.
Chem Pharm Bull (Tokyo). 2017; 65(2):134-142.
3) Onuki Y, Funatani C, Yamamoto Y, Fukami T, Koide T, Hayashi Y, Takayama K.
Chem Pharm Bull (Tokyo). 2017;65(5):487-491.
4) Hayashi Y, Tsuji T, Shirotori K, Oishi T, Kosugi A, Kumada S, Hirai D, Takayama K, Onuki Y.
Int J Pharm. 2017; 532(1):82-89
5) Leong KH, Sahoo P, Nyamathulla S, Onuki Y, Takayama K, Chung LY,
React Funct Polym. 2017 Oct;119: 145-155.
6) Yamamoto Y, Fukami T, Onuki Y, Metori K, Suzuki T, Koide T,
Vib Spectrosc. 2017 Nov;93: 17-22.
| 2016
1) Uehara N, Hayashi Y, Mochida H, Otoguro S, Onuki Y, Obata Y, Takayama K.
Drug Dev Ind Pharm. 2016 Jan; 42(1):116-22.
2) Onuki Y, Obata Y, Kawano K, Sano H, Matsumoto R, Hayashi Y, Takayama K.
Mol Pharm. 2016 Feb; 13(2):369-78.
3) Onuki Y, Kida C, Funatani C, Hayashi Y, Takayama K.
Int J Cosmet Sci. 2016 Jun; 38(3):272-8.
4) Yamamoto Y, Kumetani M, Onuki Y, Koide T, Suzuki T, Fukami T.
Chem Pharm Bull (Tokyo). 2016 Jul; 64(7):1047-55.
5) Okada N, Hayashi Y, Onuki Y, Miura T, Obata Y, Takayama K.
Chem Pharm Bull (Tokyo). 2016 Aug; 64(8):1142-8.
6) Onuki Y, Yokokawa M, Utsumi S, Obata Y, Machida Y, Seike C, Hayashi Y, Takayama K.
Chem Pharm Bull (Tokyo). 2016 Nov; 64(11):1616-21.
| 2015
J Pharm Health Car Sci. 2015 Mar; 1:9
2) Yamamoto Y, Fukami T, Koide T, Onuki Y, Suzuki T, Katori N, Tomono K.
Chem Pharm Bull. 2015 Apr;63(4):263-72.
3) Onuki Y, Funatani C, Yokawa T, Yamamoto Y, Fukami T, Koide T, Obata Y, Takayama K.
Chem Pharm Bull. 2015 May;63(5):377-83.
4) Onuki Y, Machida Y, Yokawa T, Seike C, Sakurai S, Takayama K.
Chem Pharm Bull. 2015 Jun;63(6):457-62.
5) Inoue Y, Iwazaki Y, Onuki Y, Funatani C, Murata I, Kanamoto I.
Chem Pharm Bull. 2015 Jul;63(7):519-24.
6) Onuki Y, Hasegawa N, Horita A, Ueno N, Kida C, Hayashi Y, Obata Y, Takayama K.
Chem Pharm Bull. 2015 Nov;63(11):901-6.
富山大学大学院医学薬学研究部(薬学) 製剤設計学講座 〒930−0194 富山県富山市杉谷2630 薬学部研究棟(U3) 6F
©2015-2023 Laboratory of Pharmaceutical technology, University of Toyama. All Rights Reserved.